Heparanase multiple effects in cancer

Thrombosis Research

Volumn 133, Issue SUPPL. 2, 2014, Pages

  Nadir, Yona ^a   Brenner, Benjamin ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Cancer; Enzymatic; Heparanase; Non enzymatic; Procoagulant

Indexed keywords

HEPARAN SULFATE; HEPARANASE; PROCOAGULANT; PROTEOHEPARAN SULFATE; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN A; VASCULOTROPIN C; BETA GLUCURONIDASE;

ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; CANCER GROWTH; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; DISSOCIATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; INTRACELLULAR SIGNALING; METASTASIS; PRIORITY JOURNAL; THROMBOCYTE; BLOOD; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASMS; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

BLOOD COAGULATION; GLUCURONIDASE; HEPARITIN SULFATE; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84901407297     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(14)50015-1     Document Type: Article

References (61)

1. Y. Friedmann, I. Vlodavsky, H. Aingorn, A. Aviv, T. Peretz, and I. Pecker et al. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis Am J Pathol 157 2000 1167 1175
2. T. Sato, A. Yamaguchi, T. Goi, Y. Hirono, K. Takeuchi, and K. Katayama et al. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis J Surg Oncol 87 2004 174 181 (Pubitemid 39167384)
3. X. Xu, R.M. Quiros, J.B. Maxhimer, P. Jiang, R. Marcinek, and K.B. Ain et al. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: A potential role in tumor metastasis Clin Cancer Res 9 2003 5968 5979 (Pubitemid 38018083)
4. O.N. El-Assal, A. Yamanoi, T. Ono, H. Kohno, and N. Nagasue The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma Clin Cancer Res 7 2001 1299 1305 (Pubitemid 32708684)
5. A.W. Kim, X. Xu, E.F. Hollinger, P. Gattuso, C.V. Godellas, and R.A. Prinz Human heparanase-1 gene expression in pancreatic adenocarcinoma J Gastrointest Surg 6 2002 167 172 (Pubitemid 40433568)
6. J. Rohloff, J. Zinke, K. Schoppmeyer, A. Tannapfel, H. Witzigmann, and J. Mossner et al. Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma Br J Cancer 86 2002 1270 1275
7. K. Gohji, M. Okamoto, S. Kitazawa, M. Toyoshima, J. Dong, and Y. Katsuoka et al. Heparanase protein and gene expression in bladder cancer J Urol 166 2001 1286 1290 (Pubitemid 32862157)
8. K. Gohji, H. Hirano, M. Okamoto, S. Kitazawa, M. Toyoshima, and J. Dong et al. Expression of three extracellular matrix degradative enzymes in bladder cancer Int J Cancer 95 2001 295 301 (Pubitemid 32847039)
9. Y. Shinyo, J. Kodama, A. Hongo, M. Yoshinouchi, and Y. Hiramatsu Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer Ann Oncol 14 2003 1505 1510 (Pubitemid 37304605)
10. J.B. Maxhimer, R.M. Quiros, R. Stewart, K. Dowlatshahi, P. Gattuso, and M. Fan et al. Heparanase-1 expression is associated with the metastatic potential of breast cancer Surgery 132 2002 326 333 (Pubitemid 35024780)
11. M. Takaoka, Y. Naomoto, T. Ohkawa, H. Uetsuka, Y. Shirakawa, and F. Uno et al. Heparanase expression correlates with invasion and poor prognosis in gastric cancers Lab Invest 83 2003 613 622 (Pubitemid 36618040)
12. W. Tang, Y. Nakamura, M. Tsujimoto, M. Sato, X. Wang, and K. Kurozumi et al. Heparanase: A key enzyme in invasion and metastasis of gastric carcinoma Mod Pathol 15 2002 593 598 (Pubitemid 34666461)
13. T. Ogishima, H. Shiina, J.E. Breault, L. Tabatabai, W.W. Bassett, and H. Enokida et al. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer Clin Cancer Res 11 2005 1028 1036 (Pubitemid 40175750)
14. P. Beckhove, B.M. Helmke, Y. Ziouta, M. Bucur, W. Dorner, and C. Mogler et al. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis Clin Cancer Res 11 2005 2899 2906 (Pubitemid 40525191)
15. S. Mikami, K. Ohashi, Y. Usui, T. Nemoto, K. Katsube, and M. Yanagishita et al. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas Jpn J Cancer Res 92 2001 1062 1073 (Pubitemid 33041175)
16. T. Kelly, H.Q. Miao, Y. Yang, E. Navarro, P. Kussie, and Y. Huang et al. High heparanase activity in multiple myeloma is associated with elevated microvessel density Cancer Res 63 2003 8749 8756 (Pubitemid 38064053)
17. M. Bitan, A. Polliack, G. Zecchina, A. Nagler, Y. Friedmann, and L. Nadav et al. Heparanase expression in human leukemias is restricted to acute myeloid leukemias Exp Hematol 30 2002 34 41 (Pubitemid 34059215)
18. S.Y. Schubert, N. Ilan, M. Shushy, O. Ben-Izhak, I. Vlodavsky, and O. Goldshmidt Human heparanase nuclear localization and enzymatic activity Lab Invest 84 2004 535 544 (Pubitemid 38858462)
19. T. Ohkawa, Y. Naomoto, M. Takaoka, T. Nobuhisa, K. Noma, and T. Motoki et al. Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation Lab Invest 84 2004 1289 1304 (Pubitemid 40063695)
20. I. Doweck, V. Kaplan-Cohen, I. Naroditsky, E. Sabo, N. Ilan, and I. Vlodavsky Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival Neoplasia 8 2006 1055 1061 (Pubitemid 44936155)
21. J. Folkman, M. Klagsbrun, J. Sasse, M. Wadzinski, D. Ingber, and I. Vlodavsky A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane Am J Pathol 130 1988 393 400 (Pubitemid 18076374)
22. I. Vlodavsky, J. Folkman, R. Sullivan, R. Fridman, R. Ishai-Michaeli, and J. Sasse et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix Proc Natl Acad Sci U S A 84 1987 2292 2296 (Pubitemid 17075857)
23. M. Elkin, N. Ilan, R. Ishai-Michaeli, Y. Friedmann, O. Papo, and I. Pecker et al. Heparanase as mediator of angiogenesis: mode of action FASEB J 15 2001 1661 1663
24. I. Vlodavsky, H.Q. Miao, B. Medalion, P. Danagher, and D. Ron Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor Cancer Metastasis Rev 15 1996 177 186 (Pubitemid 26236115)
25. K. Mahtouk, D. Hose, P. Raynaud, M. Hundemer, M. Jourdan, and E. Jourdan et al. Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma Blood 109 2007 4914 4923 (Pubitemid 46827789)
26. R.D. Sanderson, Y. Yang, L.J. Suva, and T. Kelly Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis Matrix Biol 23 2004 341 352 (Pubitemid 39469549)
27. R.D. Sanderson, and Y. Yang Syndecan-1: A dynamic regulator of the myeloma microenvironment Clin Exp Metastasis 25 2008 149 159
28. C. Seidel, A. Sundan, M. Hjorth, I. Turesson, I.M. Dahl, and N. Abildgaard et al. Serum syndecan-1: A new independent prognostic marker in multiple myeloma Blood 95 2000 388 392 (Pubitemid 30041645)
29. A. Purushothaman, T. Uyama, F. Kobayashi, S. Yamada, K. Sugahara, and A.C. Rapraeger et al. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis Blood 115 2010 2449 2457
30. Y. Yang, S. Yaccoby, W. Liu, J.K. Langford, C.Y. Pumphrey, and A. Theus et al. Soluble syndecan-1 promotes growth of myeloma tumors in vivo Blood 100 2002 610 617 (Pubitemid 34761126)
31. Y. Yang, V. Macleod, H.Q. Miao, A. Theus, F. Zhan, and J.D. Shaughnessy Jr. et al. Heparanase enhances syndecan-1 shedding: A novel mechanism for stimulation of tumor growth and metastasis J Biol Chem 282 2007 13326 13333 (Pubitemid 47100527)
32. S. Gingis-Velitski, A. Zetser, M.Y. Flugelman, I. Vlodavsky, and N. Ilan Heparanase induces endothelial cell migration via protein kinase B/Akt activation J Biol Chem 279 2004 23536 23541 (Pubitemid 38685666)
33. V. Doviner, B. Maly, V. Kaplan, S. Gingis-Velitski, N. Ilan, and I. Vlodavsky et al. Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence Mod Pathol 19 2006 878 888 (Pubitemid 43780459)
34. A. Zetser, Y. Bashenko, H.Q. Miao, I. Vlodavsky, and N. Ilan Heparanase affects adhesive and tumorigenic potential of human glioma cells Cancer Res 63 2003 7733 7741 (Pubitemid 37466704)
35. V. Cohen-Kaplan, I. Naroditsky, A. Zetser, N. Ilan, I. Vlodavsky, and I. Doweck Heparanase induces VEGF C and facilitates tumor lymphangiogenesis Int J Cancer 123 2008 2566 2573
36. K. Alitalo, and P. Carmeliet Molecular mechanisms of lymphangiogenesis in health and disease Cancer Cell 1 2002 219 227 (Pubitemid 41039145)
37. V. Cohen-Kaplan, I. Doweck, I. Naroditsky, I. Vlodavsky, and N. Ilan Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression Cancer Res 68 2008 10077 10085
38. L. Fux, N. Feibish, V. Cohen-Kaplan, S. Gingis-Velitski, S. Feld, and C. Geffen et al. Structure-function approach identifies a COOH-terminal domain that mediates heparanase signaling Cancer Res 69 2009 1758 1767
39. M.D. Hulett, J.R. Hornby, S.J. Ohms, J. Zuegg, C. Freeman, and J.E. Gready et al. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase Biochemistry 39 2000 15659 15667 (Pubitemid 32038227)
40. G. Abboud-Jarrous, Z. Rangini-Guetta, H. Aingorn, R. Atzmon, S. Elgavish, and T. Peretz et al. Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase J Biol Chem 280 2005 13568 13575 (Pubitemid 40517249)
41. Y. Nadir, T. Katz, G. Sarig, R. Hoffman, A. Oliven, and J.M. Rowe et al. Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor Haematologica 90 2005 1549 1556 (Pubitemid 41658768)
42. M. De Cicco The prothrombotic state in cancer: pathogenic mechanisms Critical reviews in oncology/hematology 50 2004 187 196 (Pubitemid 38746533)
43. Y. Nadir, B. Brenner, A. Zetser, N. Ilan, I. Shafat, and E. Zcharia et al. Heparanase induces tissue factor expression in vascular endothelial and cancer cells J Thromb Haemost 4 2006 2443 2451 (Pubitemid 44575440)
44. Y. Nadir, B. Brenner, L. Fux, I. Shafat, J. Attias, and I. Vlodavsky Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII Haematologica 95 2010 1927 1934
45. Y. Nadir, Y. Kenig, A. Drugan, I. Shafat, and B. Brenner An assay to evaluate heparanase procoagulant activity Thromb Res 128 2011 e3 e8
46. E. Peled, A. Rovitsky, E. Axelman, D. Norman, B. Brenner, and Y. Nadir Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin Thromb Res 130 2012 129 134
47. M. Matan, E. Axelman, B. Brenner, and Y. Nadir Heparanase procoagulant activity is elevated in women using oral contraceptives Hum Reprod 28 2013 2372 2380
48. H. Kato Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects Arterioscler Thromb Vasc Biol 22 2002 539 548 (Pubitemid 34408731)
49. B.A. Lwaleed, and P.S. Bass Tissue factor pathway inhibitor: structure, biology and involvement in disease J Pathol 208 2006 327 339 (Pubitemid 43210519)
50. Y. Nadir, B. Brenner, S. Gingis-Velitski, F. Levy-Adam, N. Ilan, and E. Zcharia et al. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells Thromb Haemost 99 2008 133 141
51. N. Iversen, A.K. Lindahl, and U. Abildgaard Elevated TFPI in malignant disease: relation to cancer type and hypercoagulation Br J Haematol 102 1998 889 895 (Pubitemid 28410516)
52. N. Iversen, A.K. Lindahl, and U. Abildgaard Elevated plasma levels of the factor Xa-TFPI complex in cancer patients Thromb Res 105 2002 33 36 (Pubitemid 34178305)
53. I. Shafat, E. Zcharia, B. Nisman, Y. Nadir, F. Nakhoul, and I. Vlodavsky et al. An ELISA method for the detection and quantification of human heparanase Biochem Biophys Res Commun 341 2006 958 963 (Pubitemid 43221759)
54. I. Vlodavsky, A. Eldor, A. Haimovitz-Friedman, Y. Matzner, R. Ishai-Michaeli, and O. Lider et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation Invasion Metastasis 12 1992 112 127
55. I. Vlodavsky, G. Abboud-Jarrous, M. Elkin, A. Naggi, B. Casu, and R. Sasisekharan et al. The impact of heparanese and heparin on cancer metastasis and angiogenesis Pathophysiol Haemost Thromb 35 2006 116 127
56. G. Bar-Sela, V. Kaplan-Cohen, N. Ilan, I. Vlodavsky, and O. Ben-Izhak Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival Histopathology 49 2006 188 193 (Pubitemid 44079702)
57. O. Ostrovsky, M. Korostishevsky, I. Levite, M. Leiba, H. Galski, and E. Gazit et al. Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel Acta Haematol 117 2007 57 64 (Pubitemid 46012426)
58. O. Ostrovsky, M. Korostishevsky, I. Levite, M. Leiba, H. Galski, and I. Vlodavsky et al. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies Leukemia 21 2007 2296 2303 (Pubitemid 350011702)
59. P.C. Winter, M.F. McMullin, and M.A. Catherwood Lack of association of the heparanase gene single-nucleotide polymorphism Arg307Lys with acute lymphoblastic leukaemia in patients from Northern Ireland Leukemia 22 2008 1629 1631 discussion 31-3
60. S. Ralph, P.E. Brenchley, A. Summers, D.D. Rosa, R. Swindell, and G.C. Jayson Heparanase gene haplotype (CGC) is associated with stage of disease in patients with ovarian carcinoma Cancer Sci 98 2007 844 849 (Pubitemid 46691821)
61. O. Ostrovsky, A. Shimoni, A. Rand, I. Vlodavsky, and A. Nagler Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors Blood 115 2010 2319 2328